FRSX is trading 5% down today at $1.74 as traders continue to digest the company's newly announced all-stock strategic investment and control transaction with VisionWave.
- The transaction has raised significant concerns among investors regarding potential share dilution and execution risks.
- The stock's current weakness follows a previous drop of over 10% and likely reflects ongoing repricing and profit-taking against a broadly weaker market backdrop.